title: Proteomics of endometrial cancer diagnosis, treatment, and prognosis.
abstract: This review discusses the current status of proteomics technology in endometrial cancer diagnosis, treatment and prognosis. The first part of this review focuses on recently identified biomarkers for endometrial cancer, their importance in clinical use as well as the proteomic methods used in their discovery. The second part highlights some of the emerging mass spectrometry based proteomic technologies that promise to contribute to a better understanding of endometrial cancer by comparing the abundance of hundreds or thousands of proteins simultaneously.
authors.affiliation: Adelaide Proteomics Centre, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.|Institute for Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, Australia.
authors.forename: Parul
authors.initials: P
authors.lastname: Mittal
authors.affiliation: Adelaide Proteomics Centre, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.|Institute for Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, Australia.
authors.forename: Manuela
authors.initials: M
authors.lastname: Klingler-Hoffmann
authors.affiliation: Adelaide Proteomics Centre, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.|Institute for Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, Australia.
authors.forename: Georgia
authors.initials: G
authors.lastname: Arentz
authors.affiliation: Adelaide Proteomics Centre, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.|Institute for Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, Australia.
authors.forename: Chao
authors.initials: C
authors.lastname: Zhang
authors.affiliation: Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden, Pulau Pinang, Malaysia.
authors.forename: Gurjeet
authors.initials: G
authors.lastname: Kaur
authors.affiliation: Department of Gynaecological Oncology, Royal Adelaide Hospital, North Terrace, Adelaide, Australia.
authors.forename: Martin K
authors.initials: MK
authors.lastname: Oehler
authors.affiliation: Adelaide Proteomics Centre, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Hoffmann
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D016889:Endometrial Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D013058:Mass Spectrometry; D009363:Neoplasm Proteins / Q000032:analysis*; D011379:Prognosis; D040901:Proteomics
chemical_list: D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins
keywords: Biomarker; Endometrial cancer